Skip to main content

Site notifications

Ozempic (semaglutide) shortage collection

There is a worldwide shortage of this diabetes medicine. TGA alerts relate to the shortage in Australia.

Increased global demand for semaglutide products is impacting availability of Ozempic (semaglutide) in Australia. Alerts on the shortage of Trulicity (dulaglutide) are shown in this collection.

Read current information and updates at:
About the Ozempic (semaglutide) shortage 2022 and 2023
About the Trulicity (dulaglutide) shortage 2022 and 2023

Novo Nordisk has informed us that the supply of Ozempic (semaglutide) in Australia remains limited. They expect the supply to remain limited until the end of June 2023. We recommend that patients who are prescribed Ozempic should contact their doctor immediately to have their treatment reassessed.

Visit the Medicine shortage reports database to search for all medicines in shortage and find information about management actions.

Collection content

6 result(s) found, displaying 1 to 6

Help us improve the Therapeutic Goods Administration site